Tag: Tirzepatide
-
Beyond GLP-1: Lilly’s New Amylin Combo Raises the Stakes in Weight Loss
Eloralintide vs. Retatrutide: A Different Way to Target Weight Loss Eloralintide targets amylin receptors, while retatrutide—often called “reta”—targets GLP-1, GIP and glucagon receptors. Both…
Oct 26, 2026 -
METABOLIC HEALTH
Can Scientists Kill Fat Cells Instead of Just Shrinking Them? New CBL-514 Research Explained
An experimental drug called CBL-514 is exploring a different approach to fat reduction: triggering programmed fat-cell death. Recent clinical research raises intriguing questions about…
Oct 18, 2026